New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Posted on 16 Apr 2026
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes over time can hinder workflow and complicate patient management, particularly in women with dense breast tissue. A new system has launched that unifies multimodality breast imaging within a single interface and integrates quantitative, radiation-free volumetric data alongside standard modalities.
The QT Imaging-Olea Viewer, developed by QT Imaging in collaboration with Olea Medical, consolidates breast imaging from multiple sources into a single user interface. The platform is designed to help clinicians correlate findings across modalities and monitor patients longitudinally while reducing dependence on multiple software viewers. By streamlining interpretation and organization of imaging data, it aims to enhance clinical efficiency and support more informed patient management over time.
The viewer is optimized for QT Imaging’s Breast Acoustic CT system, which uses advanced ultrasound tomography to generate true three-dimensional volumetric breast images without ionizing radiation or painful compression. The technology is intended to provide quantitative, reproducible imaging data and is described as offering particular clinical value in dense breast tissue. Integration of these quantitative “QTscan” datasets with conventional modalities enables a more comprehensive multimodality review.
Built on Olea Medical’s visualization framework, the QT Imaging-Olea Viewer supports advanced three-dimensional rendering and quantitative assessment. The system also supports integration of artificial intelligence and machine learning (AI/ML) capabilities, including planned applications such as automated lesion segmentation and computer-aided detection (CAD). The viewer is available for demonstration at Olea Medical booth #433 during the SBI Breast Imaging Symposium, April 16–19, at the Seattle Convention Center. The product was developed under a collaboration announced in January 2026.
“Integrating quantitative, radiation-free QTscan data with mammography, digital breast tomosynthesis, MRI, and ultrasound in a single intuitive platform improves interpretive efficiency, strengthens diagnostic confidence, and supports a more comprehensive multimodality approach to breast evaluation,” said Dr. Bilal Malik, Chief Medical Officer of QT Imaging.
“Our collaboration with QT Imaging shows how advanced software and imaging innovation can seamlessly come together to benefit clinicians and patients alike,” said Faycal Djeridane, Founder and Chief Executive Officer of Olea Medical. “By integrating QT Imaging’s quantitative biomarkers into our advanced imaging platform, we’re enabling a data-rich, cohesive viewing experience that enhances diagnostic efficiency.”
Related Links
Olea Medical
QT Imaging
